Purchases and Sales Made in Q3 2023 in Sage Therapeutics, Inc. (SAGE)
This table provides information about the institutional ownership of Sage Therapeutics, Inc. (SAGE) during Q3 2023. The information is specifically focused on institutions that hold shares of Sage Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 14, 2023
Q3 2023
|
Nuveen Asset Management, LLC
Chicago, IL |
SELL
|
- |
-172K- 54.9% |
$2.88M - $8.43M
|
141K
$775K
|
|
|
Nov 14, 2023
Q3 2023
|
Ameriprise Financial Inc
Minneapolis, MN |
SELL
|
- |
-178K- 19.96% |
$2.98M - $8.7M
|
712K
$3.9M
|
|
|
Nov 14, 2023
Q3 2023
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-199K- 38.84% |
$3.33M - $9.74M
|
313K
$1.72M
|
|
|
Nov 13, 2023
Q3 2023
|
Black Rock Inc.
New York, NY |
SELL
|
- |
-208K- 4.69% |
$3.48M - $10.2M
|
4.22M
$23.1M
|
|
|
Nov 15, 2023
Q3 2023
|
Manufacturers Life Insurance Company, The
Toronto, A6 |
SELL
|
- |
-230K- 38.66% |
$3.85M - $11.2M
|
364K
$2M
|
|
|
Nov 14, 2023
Q3 2023
|
D. E. Shaw & Co., Inc.
New York, NY |
SELL
|
- |
-249K- 55.19% |
$4.17M - $12.2M
|
202K
$1.11M
|
|
|
Nov 09, 2023
Q3 2023
|
Dimensional Fund Advisors LP
Austin, TX |
SELL
|
- |
-389K- 22.65% |
$6.51M - $19M
|
1.33M
$7.28M
|
|
|
Nov 13, 2023
Q3 2023
|
Norges Bank
Oslo, Q8 |
SELL
|
- |
-491KClosed |
$8.22M - $24M
|
0
$0
|
|
|
Nov 14, 2023
Q3 2023
|
Price T Rowe Associates Inc
Baltimore, MD |
SELL
|
- |
-498K- 46.09% |
$8.34M - $24.4M
|
582K
$3.19M
|
|
|
Nov 14, 2023
Q3 2023
|
Marshall Wace, LLP
London, X0 |
SELL
|
- |
-617K- 77.33% |
$10.3M - $30.2M
|
181K
$992K
|